Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 22, 2021, the National Research Council of Canada (NRC) announced it had completed construction of the…
On Jun. 21, 2021, Gilead Sciences announced positive data from three retrospective studies of the real-world treatment of…
On Jun. 21, 2021, Tonix Pharmaceuticals announced that it planned to develop TNX-102 SL (cyclobenzaprine HCl sublingual tablets)…
On Jun. 17, 2021, the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research granted…
On Jun. 16, 2021, Regeneron announced positive results from the largest trial assessing any monoclonal antibody treatment in…
On Jun. 15, 2021, Moderna and Magenta Investments, an industrial conglomerate in the United Arab Emirates (UAE), announced…
On Jun. 14, 2021, University of British Columbia researchers Dr. Jayachandran Kizhakkedathu, Dr. Caigan Du and Dr. Christopher…
On Jun. 14, 2021, Cocrystal Pharma announced the selection of CDI-45205 as the lead compound for further development…
On Jun. 11, 2021, Moderna and Tabuk Pharmaceutical announced an agreement to commercialize the Moderna COVID-19 Vaccine and…
On Jun. 8, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…
On Jun. 7, 2021, MediciNova announced it had initiated a sheep study to investigate MN-166 (ibudilast) in an…
On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…
On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for…
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…
On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…
On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…
Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…
On May 24, 2021, Moderna and Aldevron announced their expanded collaboration in support of the Moderna COVID-19 Vaccine…
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…
On May 19, 2021, Megan A. Cooper, MD, PhD, an associate professor of pediatrics at Washington University School…
On May 13, 2021, CureVac announced together with its collaboration partner GSK, first preclinical data in a rat…
On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…
On May 5, 2021, Moderna announced initial data from its Phase 2 study showing that a single 50…